Company: BIVIW
Filing Date: 2025-07-22
Form Type: S-1/A
Source: 0001520138-25-000216
Chunk: 51

Company: BIOVIE INC.
Filing Date: 2025-07-22
Form: S-1/A
Chunk 51
---
 may be extended. If we are unable
to obtain patent term extension or the term of any such extension is less than we request, the period during which we can enforce our
patent rights for the applicable drug candidate will be shortened and our competitors may obtain approval to market competing products
sooner. As a result, our revenue from applicable products could be reduced. Further, if this occurs, our competitors may take advantage
of our investment in development and trials by referencing our clinical and nonclinical data and launch their product earlier than might
otherwise be the case, and our competitive position, business, financial condition, results of operations and prospects could be materially
harmed.

We may not be able to protect our intellectual property rights throughout the world.

Filing, prosecuting, maintaining, defending and
enforcing patents on our drug candidates in all countries throughout the world would be prohibitively expensive, and consequently our
intellectual property rights in some countries outside the United States may be less extensive than those in the United States. In addition,
the laws of some foreign countries do not protect intellectual property rights to the same extent as federal and state laws in the United
States. Consequently, we may not be able to prevent third parties from practicing our inventions in all countries outside the United States,
or from selling or importing products made using our inventions in and into the United States or other jurisdictions. Competitors may
use our technologies in jurisdictions where we have not obtained patents to develop their own products and may export otherwise infringing
products to territories where we have patents, but enforcement rights are not as strong as those in the United States. These products
may compete with our drug candidates and our patents or other intellectual property rights may not be effective or sufficient to prevent
them from competing.

Many companies have encountered significant problems
in protecting and defending intellectual property rights in foreign jurisdictions. The legal systems of some countries do not favor the
enforcement or protection of patents, trade secrets and other intellectual property, which could make it difficult for us to stop the
infringement of our patents or marketing of competing products in violation of our intellectual property and proprietary rights generally.
Proceedings to enforce our intellectual property rights in foreign jurisdictions could result in substantial costs and divert our efforts
and attention from other aspects of our business, could put our patents at risk of being invalidated or interpreted narrowly and our patent
applications at risk of not issuing and could provoke third parties to assert claims against us. We may not prevail in any lawsuits that
we initiate, and the